Marcin Frąckiewicz

Marcin Frąckiewicz

Marcin Frąckiewicz is the founder and CEO of TS2 Space, a satellite communications company working with customers worldwide. His experience spans satellite communications, telecommunications and technology ventures. He graduated from the Warsaw School of Economics (SGH) and writes about space technology, artificial intelligence, stocks and the technology companies and industries he follows. Follow Marcin Frąckiewicz on Google News, Facebook or LinkedIn.

London Stock Exchange at Record Highs – Inside the Historic Market’s Brexit Battle and 2025 Revival

London Stock Exchange at Record Highs – Inside the Historic Market’s Brexit Battle and 2025 Revival

Founded over 300 years ago, the London Stock Exchange has a rich heritage. It began informally in 1698 when John Castaing, a London broker, first published stock and commodity prices at Jonathan’s Coffee Houseinvestopedia.com. By 1801, stockbrokers seeking a more orderly market created a regulated exchange with membership rules and fees – marking the birth of the modern LSEinvestopedia.com. Throughout the 19th and 20th centuries, the exchange grew alongside the British Empire and industrial revolution, listing companies from around the world. Major reforms shaped its development: for example, the “Big Bang” deregulation in 1986 suddenly abolished fixed commissions and embraced electronic trading, catapulting the LSE into a new era of global competitivenessinvestopedia.com.
9 October 2025
FTSE 100’s Record Run: Inside London’s Blue-Chip Rally and What’s Next

FTSE 100’s Record Run: Inside London’s Blue-Chip Rally and What’s Next

The FTSE 100 is the flagship stock index of the London Stock Exchange, tracking the 100 largest companies by market capitalization listed in the UK. Often called the “Footsie,” it serves as a barometer of British large-cap equities. The index is market-cap weighted, meaning each company’s influence on the index is proportional to its market valuetheguardian.com. In practical terms, bigger companies like Shell or HSBC move the FTSE 100 far more than smaller constituents. The FTSE 100 is maintained by FTSE Russell and is updated in real time during trading hours. It’s also a basis for countless investment products – from index funds and ETFs to futures contracts – giving investors a way to track or trade the overall London market easily.
AMD Stock Skyrockets on AI Mega-Deal: Inside the 2025 Rally, Financials & Rivalry

AMD Stock Skyrockets on AI Mega-Deal: Inside the 2025 Rally, Financials & Rivalry

Advanced Micro Devices has been one of 2025’s top semiconductor stocks, staging a dramatic rally after a volatile 2024. As of early October, AMD shares traded around $230+ – nearly double their level at the start of the yearfinviz.com. The stock had already climbed ~30% year-to-date by late Septemberts2.techts2.tech, outperforming both the S&P 500 and the Philly Semiconductor Index. Then came an explosive surge in October: AMD’s stock leapt about 29% in a matter of days, topping $213 by Oct. 7stockstotrade.com, and continued to rally into Oct. 8 with a further ~10% intraday jumpstockstotrade.com. In fact, across the first three sessions of October, AMD notched its best three-day run in years, driven by a wave of AI-fueled optimism.
Duolingo Stock Surges on AI Buzz – Latest Price, Bold Forecasts & Big Risks in 2025

Duolingo Stock Surges on AI Buzz – Latest Price, Bold Forecasts & Big Risks in 2025

Duolingo’s stock has experienced whiplash in 2025. After a strong first half, DUOL tumbled nearly 50% from summer highs, erasing most of its prior 12-month gainsmarketbeat.com. Over the past three months the stock slid 35%, dramatically underperforming both the edtech industry and the S&P 500 in that spannasdaq.com. This “nasty slide” sent shares down toward the $280s by late Septembermarketbeat.com. Investors grew skittish over post-pandemic user trends and fears that emerging AI tools could steal Duolingo’s thundermarketbeat.com.
Amazon Stock Surges on New AI Push – Latest Price, Key News & 2025 Outlook

Amazon Stock Surges on New AI Push – Latest Price, Key News & 2025 Outlook

As of October 8, 2025, Amazon’s stock trades around $225 per sharestockanalysis.com. It has risen modestly in early October, bouncing from about $219 at the start of the month to the mid-$220s rangestockanalysis.com. This week’s ~1.5% uptick follows a period of volatility in late September. Year-to-date, AMZN is roughly flat to slightly up, lagging the broader S&P 500 and most other “Magnificent Seven” tech giants. Notably, Amazon hit an all-time high near $242 in early February 2025, but a summer tech sell-off and profit-taking pulled the stock down about 10% from that peakts2.tech.
Tempus AI (TEM) Stock Skyrockets on AI Healthcare Breakthroughs – What Investors Need to Know

Tempus AI (TEM) Stock Skyrockets on AI Healthcare Breakthroughs – What Investors Need to Know

Tempus AI, Inc. is an American health technology company founded in 2015 by entrepreneur Eric Lefkofsky. Headquartered in Chicago, Tempus was born from Lefkofsky’s personal mission to improve cancer care after his wife’s battle with breast canceren.wikipedia.org. The company’s core focus is on applying AI and data analytics to personalized medicine. Tempus has built what it calls an “operating system” for healthcare: a platform that ingests vast amounts of clinical and molecular data and makes it accessible for treatment decisions and researchinsidermonkey.com. Its goal is to enable doctors and scientists to leverage big data and AI algorithms to tailor treatments to individual patients – improving outcomes in cancer and other diseases.
Rare Interstellar Comet 3I/ATLAS – a 10-Billion-Year-Old Time Capsule – Flies Past Mars

Rare Interstellar Comet 3I/ATLAS – a 10-Billion-Year-Old Time Capsule – Flies Past Mars

Humanity has waited a long time to study a comet from another star – and suddenly, within a decade, we’ve had three. 3I/ATLAS is the latest of these rare interstellar interlopers. It was first detected moving through the outer Solar System in June 2025 with an exceptionally eccentric orbit. Follow-up observations quickly confirmed what its speed and trajectory implied: this object was not bound to the Sun’s gravityts2.tech. By July 2025, the Minor Planet Center designated it the third interstellar object ever foundts2.tech. Like its predecessors – the cigar-shaped 1I/‘Oumuamua and cometary 2I/Borisov – 3I/ATLAS is an outsider: it originated around a distant star and is merely passing through our cosmic neighborhoodesa.int.
Google’s Pixel 10 Pro Fold Shakes Up the Smartphone Wars with AI Tricks, Durability & Bold Design

Google’s Pixel 10 Pro Fold Shakes Up the Smartphone Wars with AI Tricks, Durability & Bold Design

Google’s new Pixel 10 Pro Fold is the star of its 2025 lineup – a device that blends cutting-edge hardware with Google’s latest AI software. This foldable phone is branded as the “Pro Fold” variant of the Pixel 10 family, emphasizing that it shares the same core specs and AI features as the Pixel 10 Pro slab phonests2.tech. When closed, it looks like a typical premium smartphone with a 6.4″ OLED display; opened up, it reveals a spacious 8″ tablet-like screen – slightly larger than its predecessor and rival Galaxy foldsts2.tech. The design retains Pixel’s signature aesthetics, but with notable engineering upgrades: Google redesigned the hinge mechanism to a gearless system, which not only makes folding motion smoother but is rated for over 100,000 folds without failurets2.tech. In practical terms, Google says the hinge should last 10+ years of average use – addressing durability concerns that often plague foldables.
Xenetic Biosciences (XBIO) Stock Skyrockets – Is the Biotech’s 2025 Rally for Real?

Xenetic Biosciences (XBIO) Stock Skyrockets – Is the Biotech’s 2025 Rally for Real?

Xenetic’s stock was relatively quiet for most of 2025 until early October, when it suddenly erupted. By Oct 8, 2025, XBIO had skyrocketed to levels not seen in years. On that day alone, the stock soared 123% to $9.58finanzen.ch, after touching intraday highs well above $10. This move extended a remarkable run from under $3.50 at the start of the week to nearly $12-13 intraday on Oct 8ainvest.com. In fact, at one point XBIO was up about +195% in a single session according to real-time trackerstimothysykes.com. Such gains are extraordinary – even by penny stock standards – and placed XBIO among the top percentage gainers across the entire Nasdaq.
Plant-Based Food Stock Goes Crypto: Above Food (ABVE) Skyrockets in 2025

Plant-Based Food Stock Goes Crypto: Above Food (ABVE) Skyrockets in 2025

Above Food Ingredients Inc. is a Canadian plant-based food tech company that went public via SPAC merger in 2024 Stocktwits. In 2025, its stock ABVE has been on a wild ride – climbing from penny-stock levels to over $4, an almost 8-fold increase in under a year Marketbeat. This meteoric rise comes as Above Food pivots beyond organic grains into gold-backed cryptocurrencies and next-gen financial tech, capturing investor imagination. Below, we dive into Above Food’s mission, business model, financials, stock performance, forecasts, expert commentary, strategic moves, ESG profile, and the latest news driving this micro-cap’s buzz.
Cipher Mining (CIFR) Stock Skyrockets on AI Pivot & Bitcoin Boom – Next Crypto Powerhouse?

Cipher Mining (CIFR) Stock Skyrockets on AI Pivot & Bitcoin Boom – Next Crypto Powerhouse?

Cipher Mining Inc. is a pure-play Bitcoin miner operating industrial-scale data centers with a focus on ultra-low-cost powerts2.tech. The company strategically locates its facilities in regions with cheap, renewable-rich electricity, often building behind-the-meter or adjacent to wind and solar farmsts2.techts2.tech. Its flagship “Black Pearl” site near Odessa, TX is a 150 MW facility designed for both Bitcoin mining and high-performance computing workloadsts2.tech.
Adaptimmune Therapeutics (ADAP) Stock Skyrockets 42% – Is This Biotech Turnaround for Real?

Adaptimmune Therapeutics (ADAP) Stock Skyrockets 42% – Is This Biotech Turnaround for Real?

Adaptimmune’s stock has been on a rollercoaster in 2025, epitomizing the volatility of small-cap biotech. After a prolonged decline to mere pennies, ADAP staged a spectacular rally in late September. On Sept 19, heavy trading momentum saw the stock open at just $0.08 and close at $0.16 – a 98% single-day jump. It didn’t stop there: in after-hours trading, ADAP leapt another 30% to $0.2020 Nasdaq despite no new company news that day Nasdaq. This frenzy was highlighted in market reports as one of the most active stocks, with 705 million shares changing hands Nasdaq.
8 October 2025
CrowdStrike Stock Skyrockets Amid Cybersecurity Boom – Is the Rally Justified? (2025 Update)

CrowdStrike Stock Skyrockets Amid Cybersecurity Boom – Is the Rally Justified? (2025 Update)

Sources: Official company reports and press releases; Yahoo Finance and Zacks Investment Research; Reuters and CNBC interviews; TS2 Tech stock analysis and cybersecurity newsts2.technasdaq.commarkets.financialcontent.commarketbeat.comts2.techsiliconangle.comts2.tech. These provide the latest financial data, expert commentary, and industry context as of October 8, 2025.
Moderna, Inc. (MRNA) Stock Update – Oct 8 2025: Will the mRNA Trailblazer Bounce Back or Sink Further?

Moderna, Inc. (MRNA) Stock Update – Oct 8 2025: Will the mRNA Trailblazer Bounce Back or Sink Further?

Moderna’s stock was a market darling during the pandemic but has suffered a long decline. On Oct 7 2025, the stock closed at $27.34, down roughly 0.7% from $27.54 on the prior sessionstockinvest.us. Technical analysts at Stockinvest.us noted the shares were near the upper part of a wide falling trend and predicted a possible trading range of $26.40–$28.73 on Oct 8, with longer‑term support around $26 and resistance near $31stockinvest.us. While short‑term signals were positive, they cautioned that the overall downward trend remainsstockinvest.us.
Why Intellia Therapeutics’ Stock Could Be a Gene‑Editing Goldmine in 2025 – Deep Dive into NTLA’s Prospects

Why Intellia Therapeutics’ Stock Could Be a Gene‑Editing Goldmine in 2025 – Deep Dive into NTLA’s Prospects

Intellia’s October rally was triggered by longer‑term Phase 1 results for nexiguran ziclumeran, an in‑vivo CRISPR therapy for transthyretin amyloidosis. A GlobeNewswire release reported that a single dose produced a rapid, deep and durable reduction of serum TTR levels—mean reduction 92 % at 24 months and 90 % at 36 monthsglobenewswire.com. Patients also showed clinical improvements or stabilization of neuropathy and cardiac markersglobenewswire.com, and safety findings were mostly mild infusion‑related eventsglobenewswire.com. CEO John Leonard said the data “demonstrate rapid, deep and durable TTR reductions with meaningful clinical improvements” and reiterated plans to complete enrolment in the Phase 3 MAGNITUDE‑2 trial in the first half of 2026globenewswire.comglobenewswire.com.
CRISPR Therapeutics Stock Update (Oct 8 2025): Why Gene‑Editing Bulls See Big Upside

CRISPR Therapeutics Stock Update (Oct 8 2025): Why Gene‑Editing Bulls See Big Upside

According to AAII, CRSP’s share price on 8 Oct 2025 closed at $77.727, up 10.06 % from the previous close. The stock traded between $70.77 and $78.38 that day and has risen ~20 % during October. Over the prior year the share price ranged from $30.04 to $73.95, and year‑to‑date performance stood at +97.5 %. Trading volume on INDmoney’s quote was 3.1 million sharesindmoney.com.
8 October 2025
Intellia Therapeutics (NTLA) Soars on CRISPR Breakthroughs – Latest Updates & Stock Outlook

Intellia Therapeutics (NTLA) Soars on CRISPR Breakthroughs – Latest Updates & Stock Outlook

Intellia Therapeutics, Inc. is a clinical-stage biotechnology company at the forefront of CRISPRgene editing medicines. Headquartered in Cambridge, MA, Intellia was one of the first companies to harness CRISPR-Cas9 technology to develop potential in vivo therapies – treatments delivered directly into the body to edit genes inside patients’ cells. In fact, Intellia reported the first-ever clinical evidence that CRISPR could provide a therapeutic benefit in humans via in-body gene editing, showing in 2021 that a one-time IV infusion could drastically lower a disease-causing protein in patients ts2.tech. This pioneering achievement, accomplished with their transthyretin amyloidosis program, has put Intellia on the map as a trailblazer in genomic medicine.
TSMC Stock Soars on AI Boom: Record Highs, Big Ambitions & Geopolitical Risks (Oct 2025 Update)

TSMC Stock Soars on AI Boom: Record Highs, Big Ambitions & Geopolitical Risks (Oct 2025 Update)

Taiwan Semiconductor Manufacturing Co. is the world’s largest contract chipmaker, producing advanced semiconductors for clients like Apple, NVIDIA, AMD, and many otherstaiwannews.com.twts2.tech. Rather than selling its own branded chips, TSMC builds chips to order, focusing on cutting-edge manufacturing processes. This model has made TSMC a pillar of global tech supply chains and given it an estimated 60%+ market share of the overall foundry marketts2.tech.
1 307 308 309 310 311 419
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

AerCap Holdings

NYSE: AER 92/100
#2 BUY

Uber Technologies

NYSE: UBER 90/100
#3 BUY

Taiwan Semiconductor Manufacturing

NYSE: TSM 89/100
#4 ACCUMULATE

dLocal

NASDAQ: DLO 86/100
#5 ACCUMULATE

Tapestry

NYSE: TPR 84/100
View full portfolio
Editorial model selection. Not personalised advice.